Study Week: Selected textbooks only 1899 each—eBooks & softcovers on sale! Shop now >>

Hematologic Malignancies
cover

Chronic Myeloid Leukemia

Editors: Hehlmann, Rüdiger (Ed.)

  • Presents state-of-the-art reviews of key issues relating to chronic myeloid leukemia
  • Covers a wide range of management topics
  • Discusses prognostic aspects and early response prediction
  • Examines the changing face and cost of care 
おすすめポイントをすべて見る

書籍の購入

イーブック ¥12,583
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • イーブック版は、まもなく発売予定です。
  • 予定日: July 9, 2021
  • ISBN 978-3-030-71913-5
  • ウォーターマーク付、 DRMフリー
  • ファイル形式:
  • ebooks can be used on all reading devices
ハードカバー ¥15,729
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • 予定日: July 9, 2021
  • ISBN 978-3-030-71912-8
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
この書籍について

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the impact of availability of generic imatinib. 


著者について

Rüdiger Hehlmann is a Professor of Medicine at the Mannheim Medical Faculty of the University of Heidelberg, Germany.

Founder and Chair, European LeukemiaNet (ELN)

Founder and chair of the German CML Study Group 1982-2017

Former Secretary General

International Association of Comparative Research on Leukemia & Related Diseases (IACRLRD)

Former Chief of Medicine, Dean & President

German Society of Hematology and Oncology

Honorary member of the Polish and German Societies for Hematology and Oncology

Current focus: promotion of cooperative research for curing leukemia


書籍の購入

イーブック ¥12,583
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • イーブック版は、まもなく発売予定です。
  • 予定日: July 9, 2021
  • ISBN 978-3-030-71913-5
  • ウォーターマーク付、 DRMフリー
  • ファイル形式:
  • ebooks can be used on all reading devices
ハードカバー ¥15,729
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • 予定日: July 9, 2021
  • ISBN 978-3-030-71912-8
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
Loading...

この書籍のサービス情報

あなたへのおすすめ

Loading...

書誌情報

Bibliographic Information
Book Title
Chronic Myeloid Leukemia
Editors
  • Rüdiger Hehlmann
Series Title
Hematologic Malignancies
Copyright
2021
Publisher
Springer International Publishing
Copyright Holder
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
イーブック ISBN
978-3-030-71913-5
DOI
10.1007/978-3-030-71913-5
ハードカバー ISBN
978-3-030-71912-8
Series ISSN
2197-9766
Edition Number
2
Number of Pages
X, 273
Number of Illustrations
7 b/w illustrations, 35 illustrations in colour
Topics